{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:19:41Z","timestamp":1788009581747,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jneuroim.2009.10.001","type":"journal-article","created":{"date-parts":[[2009,10,25]],"date-time":"2009-10-25T04:10:08Z","timestamp":1256443808000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Conversion of peripheral CD4+CD25\u2212 T cells to CD4+CD25+ regulatory T cells by IFN-\u03b3 in patients with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"217","author":[{"given":"Shuo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jneuroim.2009.10.001_bib1","first-page":"17","article-title":"Tregs and rheumatoid arthritis","volume":"33","author":"Anderson","year":"2008","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.jneuroim.2009.10.001_bib2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.10.001_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2009.10.001_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain-Barr\u00e9 syndrome","volume":"192","author":"Chi","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.10.001_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8027.2008.00158.x","article-title":"Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Chi","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"4","key":"10.1016\/j.jneuroim.2009.10.001_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.10.001_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.10.001_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMra055446","article-title":"Regulation of immune responses by T cells","volume":"354","author":"Hong","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5609","key":"10.1016\/j.jneuroim.2009.10.001_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2009.10.001_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain-Barr\u00e9 syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2009.10.001_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20050855","article-title":"Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen","volume":"202","author":"Knoechel","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.10.001_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.20041201","article-title":"Conversion of CD4+CD25\u2212 cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus","volume":"201","author":"Liang","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2009.10.001_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2009.10.001_bib14","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.175.9.6107","article-title":"The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25\u2212CD4+ precursors","volume":"175","author":"Skapenko","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.10.001_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181933261","article-title":"Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy","volume":"87","author":"Tian","year":"2009","journal-title":"Transplantation"},{"issue":"17","key":"10.1016\/j.jneuroim.2009.10.001_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"Van der Mech\u00e9","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2009.10.001_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.jneuroim.2009.10.001_bib18","first-page":"2434","article-title":"Role of IFN-gamma in induction of FoxP3 and conversion of CD4+CD25\u2212 T cells to CD4+ Tregs","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.jneuroim.2009.10.001_bib19","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-\u03b3 are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.10.001_bib20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/art.23460","article-title":"Suppressor activity among CD4+CD25+ T cells is discriminated by membrane-bound tumor necrosis factor alpha","volume":"58","author":"Wang","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jneuroim.2009.10.001_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.23268","article-title":"Dysfunctional CD4+CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells","volume":"58","author":"Yan","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.10.001_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ibd.20053","article-title":"Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis","volume":"13","author":"Yu","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.10.001_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.jneuroim.2009.10.001_bib24","first-page":"192","article-title":"The critical role of TGF-beta1 in the development of induced Foxp3+ regulatory T cells","volume":"1","author":"Zheng","year":"2008","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.10.001_bib25","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.4049\/jimmunol.176.6.3321","article-title":"TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells","volume":"176","author":"Zheng","year":"2006","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809003920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809003920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:12:40Z","timestamp":1759047160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809003920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0165572809003920"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.10.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion of peripheral CD4+CD25\u2212 T cells to CD4+CD25+ regulatory T cells by IFN-\u03b3 in patients with Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}